85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05255991 (ClinicalTrials.gov)	September 2022	15/2/2022	Multinational Study of Efficacy and Safety of Inhaled Treprostinilin Subjects With Idiopathic Pulmon ...	A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Saf ...	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Not yet recruiting	40 Years	N/A	All	396	Phase 3	NULL
2	NCT04905693 (ClinicalTrials.gov)	June 2022	20/5/2021	Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Not yet recruiting	40 Years	N/A	All	792	Phase 3	NULL
3	NCT04708782 (ClinicalTrials.gov)	June 1, 2021	12/1/2021	Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis	A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled ...	Idiopathic Pulmonary Fibrosis;Interstitial Lung Disease	Drug: Placebo;Drug: Inhaled Treprostinil;Device: Treprostinil Ultrasonic Nebulizer	United Therapeutics	NULL	Recruiting	40 Years	N/A	All	396	Phase 3	United States
4	NCT00703339 (ClinicalTrials.gov)	June 2008	19/6/2008	Effects of Inhaled TreprostinilSodium for the Treatment of Pulmonary Hypertension Associated With Id ...	A Single-Dose, Dose-Escalating Study Exploring the Safety, Pharmacokinetics, and Pharmacodynamic Eff ...	Idiopathic Pulmonary Fibrosis;Pulmonary Hypertension	Drug: Treprostinil sodium for inhalation	Lung Biotechnology PBC	NULL	Terminated	35 Years	80 Years	All	1	Phase 2	United States

First Previous1Next Last